Doxorubicin, commonly known by the brand name Adriamycin, is an anthracycline chemotherapy drug used to treat many types of cancer. It is given by intravenous infusion and is often used with other cancer treatments such as surgery, radiation therapy, or additional chemotherapy medicines. Doxorubicin is powerful because it attacks rapidly dividing cancer cells, but it also requires careful monitoring because it can affect the bone marrow, heart, liver, skin, veins, and reproductive health.
The regular IV form of doxorubicin is used in cancers such as acute leukemias, lymphomas, Wilms’ tumor, neuroblastoma, bone and soft tissue sarcomas, thyroid cancer, transitional cell bladder cancer, breast cancer, and ovarian cancer. A liposomal injectable form is used in selected cancers such as Kaposi’s sarcoma, ovarian cancer, breast cancer, and multiple myeloma refractory to other treatments. Official prescribing information also highlights major boxed warnings for cardiomyopathy, extravasation and tissue necrosis, and severe myelosuppression.
The key safety message is simple: doxorubicin is effective but high-alert. Patients need blood count monitoring, infection precautions, cardiac function testing, liver function monitoring, and immediate reporting of IV site pain, redness, swelling, fever, sore throat, easy bruising, shortness of breath, chest pain, dark urine, jaundice, or pregnancy possibility.
What is doxorubicin?
Doxorubicin is an anticancer medicine from the anthracycline class.
Simple definition
Doxorubicin is a chemotherapy drug that damages cancer cell DNA and slows or stops cancer cell growth.
Brand name
The common brand name is Adriamycin.
Drug class
Doxorubicin belongs to the class called anthracyclines.
Main route
Doxorubicin is usually given through an IV line. It must not be given casually or outside proper oncology supervision because leakage into tissue can cause severe damage.
What are anthracyclines?
Anthracyclines are chemotherapy drugs used for several cancers.
How anthracyclines fight cancer
Anthracyclines interfere with cancer cell DNA. They also affect enzymes involved in DNA copying and repair. Since cancer cells divide quickly, damage to DNA can stop their growth or cause cell death.
Simple analogy
Think of a cancer cell as a photocopy machine making too many copies. Doxorubicin damages the instruction paper and jams the machine, so the cancer cell cannot keep copying itself properly.
Why normal cells are affected too
Some normal cells also divide quickly, such as bone marrow cells, hair follicle cells, and cells lining the mouth and gut. That is why doxorubicin can cause low blood counts, hair loss, mouth sores, nausea, and infection risk.
Therapeutic uses of doxorubicin
Doxorubicin is used for many cancers, either alone or in combination regimens.
Regular IV doxorubicin
The image lists the regular IV form for several cancers.
Acute leukemias
Acute leukemias are fast-growing cancers of blood-forming tissues. Doxorubicin may be used as part of combination chemotherapy.
Lymphomas
Lymphomas are cancers of lymphocytes, a type of white blood cell. Doxorubicin is an important component in some lymphoma regimens.
Wilms’ tumor
Wilms’ tumor is a kidney cancer seen in children. Doxorubicin may be part of treatment for certain risk groups.
Neuroblastoma
Neuroblastoma is a childhood cancer that develops from immature nerve cells. Doxorubicin may be used in selected treatment protocols.
Bone and soft tissue sarcomas
Sarcomas are cancers of connective tissues such as bone, muscle, fat, or soft tissue. Doxorubicin is commonly associated with sarcoma chemotherapy.
Thyroid cancer
Doxorubicin may be used in certain thyroid cancers, especially when other treatments are limited.
Transitional cell bladder cancer
Transitional cell carcinoma is a common type of bladder cancer. Doxorubicin may be included in treatment plans.
Breast and ovarian cancers
Doxorubicin is widely known in breast cancer therapy and may also be used in ovarian cancer regimens.
Liposomal doxorubicin
Liposomal doxorubicin is doxorubicin packaged in tiny fat-like particles called liposomes. This changes how the drug travels in the body and may reduce some tissue exposure while targeting tumors differently.
Kaposi’s sarcoma
The liposomal injectable form is used for AIDS-related Kaposi’s sarcoma after failure or intolerance of previous systemic chemotherapy.
Ovarian cancer
Liposomal doxorubicin is indicated for ovarian cancer that has progressed or recurred after platinum-based chemotherapy.
Multiple myeloma
Liposomal doxorubicin may be used with bortezomib in certain patients with multiple myeloma.
Breast cancer
The image also includes breast cancer among liposomal-form uses, especially in refractory settings.
Doxorubicin with other cancer treatments
With surgery
Surgery removes visible tumor tissue. Doxorubicin may be used before or after surgery depending on cancer type and treatment plan.
With radiation therapy
Radiation targets cancer cells in a specific area. Doxorubicin may be used with radiation in selected protocols, but prior radiation near the heart increases cardiac risk.
With other chemotherapy drugs
Cancer treatment often uses combinations because different drugs attack cancer cells in different ways.
How doxorubicin works
Doxorubicin works mainly by damaging DNA and interfering with cancer cell replication.
DNA intercalation
Doxorubicin can insert itself between DNA strands. This disrupts the structure of DNA.
Topoisomerase II inhibition
It interferes with topoisomerase II, an enzyme cells use to untangle DNA during replication.
Free radical formation
Doxorubicin can generate free radicals, which contribute to cancer cell killing but also contribute to heart toxicity.
Why heart toxicity happens
Heart cells are sensitive to oxidative stress. Over time, doxorubicin exposure can damage heart muscle, causing cardiomyopathy or heart failure in some patients.
Major adverse drug reactions
Severe bone marrow suppression
The image highlights severe bone marrow suppression, especially affecting leukocytes and granulocytes.
Bone marrow is the soft tissue inside bones that makes blood cells. When doxorubicin suppresses bone marrow, the body may produce fewer white blood cells, red blood cells, and platelets.
Low white blood cells
Low white blood cells increase infection risk.
Low granulocytes
Granulocytes, especially neutrophils, fight bacterial infections. Low neutrophils are called neutropenia.
Nadir timing
The image states that the nadir is reached 10 to 14 days after the dose. Nadir means the lowest point of blood cell count after chemotherapy.
Thrombocytopenia
Thrombocytopenia means low platelet count.
Why platelets matter
Platelets help blood clot. Low platelets increase risk of bruising and bleeding.
Warning signs
Patients should report easy bruising, bleeding gums, nosebleeds, black stools, blood in urine, or unusual bleeding.
Anemia
Anemia means low red blood cells or low hemoglobin.
Symptoms
Symptoms may include fatigue, weakness, dizziness, shortness of breath, pale skin, or rapid heartbeat.
Alopecia
Alopecia means hair loss. The image notes complete hair loss may occur.
Important reassurance
Hair loss from doxorubicin is usually reversible after treatment ends, though regrowth may take time.
Red urine and tears
Doxorubicin can cause red or orange-red urine and tears for 1 to 2 days after infusion.
Why this happens
The drug itself is red-colored. This discoloration is expected and reversible.
When to worry
Red urine from doxorubicin color change should fade. Blood in urine, painful urination, clots, fever, or persistent discoloration should be reported.
Cardiac toxicity
Cardiac toxicity is one of the most important doxorubicin risks.
Immediate effects
Some cardiac effects may occur soon after a dose, such as rhythm changes or acute symptoms.
Delayed effects
Irreversible cardiac symptoms may occur months or years after treatment. Official labeling warns that myocardial damage, including acute left ventricular failure, can occur, and the risk increases with cumulative dose exposure.
Symptoms to report
Patients should report rapid heartbeat, palpitations, shortness of breath, chest pain, swelling in legs, sudden fatigue, or fainting.
Hepatic toxicity
Hepatic toxicity means liver injury.
Why liver function matters
The liver helps process doxorubicin. If the liver is impaired, drug levels may rise and toxicity may increase.
Warning signs
Report persistent anorexia, vomiting, abdominal pain, itchy skin, dark urine, and jaundice.
Local thrombophlebitis
Thrombophlebitis means inflammation of a vein with possible clot irritation.
Symptoms
Symptoms may include redness, tenderness, warmth, pain, or a cord-like feeling along the vein.
Extravasation
Extravasation means the drug leaks out of the vein into surrounding tissue.
Why doxorubicin extravasation is dangerous
Doxorubicin is a vesicant. If it leaks into tissue, it can cause serious injury, including tissue necrosis, tendon injury, nerve injury, and long-term damage. DailyMed prescribing information states that extravasation can cause severe local tissue injury such as blistering, ulceration, and necrosis, and the infusion should be stopped immediately if extravasation occurs.
High-risk IV sites
The image warns that extravasation in veins near joints, such as the hand, wrist, antecubital space, or edematous extremities, may cause tissue necrosis, tendon injury, or nerve injury.
Nursing and clinical interventions
Monitor CBC with differential
CBC with differential should be monitored before each treatment and at weekly intervals after treatment as prescribed.
Why this matters
CBC helps detect neutropenia, anemia, and thrombocytopenia.
Monitor temperature frequently
Fever during chemotherapy can be dangerous because it may indicate infection during neutropenia.
Fever is urgent
Patients receiving chemotherapy should not ignore fever, chills, or signs of infection.
Use colony-stimulating drugs when prescribed
Colony-stimulating drugs such as filgrastim may be prescribed to reduce neutropenia.
What filgrastim does
Filgrastim helps the bone marrow make more neutrophils, reducing infection risk in selected patients.
Monitor bleeding
If thrombocytopenia occurs, patients should be monitored for bleeding.
Bleeding checks
Monitor gums, stool, urine, skin bruising, IV sites, and any unusual bleeding.
Monitor red urine and alopecia
Patients should be prepared for reversible red urine and hair loss.
Why counseling helps
These effects can be alarming if unexpected. Teaching reduces anxiety.
Assess baseline cardiac function
Baseline cardiac function should be assessed before treatment.
Common tests
Tests may include echocardiogram, MUGA scan, ECG, or other cardiac evaluation based on oncology protocol.
Follow cardiac function during and after therapy
Cardiac monitoring may continue during treatment and after therapy because delayed toxicity can occur.
Monitor dysrhythmias and vital signs
Dysrhythmias are abnormal heart rhythms. Vital signs should be assessed after treatment.
Cardioprotective therapy
The image mentions ACE inhibitors or dexrazoxane as possible protective agents for selected patients, such as breast cancer patients.
What dexrazoxane does
Dexrazoxane is a cardioprotective agent that may reduce anthracycline-related heart damage in selected situations.
Monitor liver function
Baseline and periodic liver function testing should be performed.
Reduce dose in hepatic toxicity
The dose may be reduced if hepatic toxicity occurs.
Avoid risky IV sites
Avoid starting IV doxorubicin in veins near joints of the hand or antecubital space when possible.
Watch for infiltration
Monitor carefully for redness, pallor, swelling, or pain during infusion into a peripheral vein.
Stop infusion immediately
If infiltration or extravasation is suspected, stop the infusion immediately and follow the institutional extravasation protocol.
Administration of doxorubicin
IV form
Doxorubicin is available in IV form as Adriamycin.
Liposomal form
It is also available in lyophilized liposome form, commonly associated with Doxil, for IV infusion.
Safe handling
Healthcare workers should wear gloves and take care when preparing the solution.
If skin contact occurs
Flush the area with water if the solution touches the skin.
Prepare the prescribed form
The prescribed form should be prepared exactly for the patient because regular doxorubicin and liposomal doxorubicin are not interchangeable without proper oncology direction.
Dose based on body size and cancer type
The dose is prescribed according to body size and type of cancer being treated.
Slow IV rate when needed
The image notes a slow IV rate may be used for red streaking along the vein or skin flushing.
IV compatibility and vesicant care
Because doxorubicin is a vesicant chemotherapy drug, administration should follow chemotherapy safety protocols.
Client instructions
Understand WBC nadir timing
The image states the critical time for WBC counts is 10 to 14 days after each doxorubicin IV treatment.
This is when infection risk may be highest.
Report infection signs
Patients should report fever, sore throat, chills, cough, burning urination, mouth sores, or unusual fatigue.
Practice careful handwashing
Handwashing reduces infection risk.
Avoid sick visitors
Patients should restrict visitors who are ill, especially during low white blood cell periods.
Wash food properly
Fresh fruits and vegetables should be washed well, and foods should be cooked properly.
Practice oral care
Frequent oral care helps prevent stomatitis and yeast superinfection in the mouth.
Report mouth problems
Patients should report black hairy tongue, mouth pain, mouth sores, diarrhea, or vaginal itching/discharge.
Report bruising or bleeding
Patients should report bleeding gums, nosebleeds, easy bruising, black stools, or unusual bleeding.
Expect hair loss and red urine
Patients should know that complete alopecia may occur and urine may be red for up to 2 days after treatment.
Complete cardiac tests
Patients should comply with cardiac function testing.
Report heart symptoms
Report rapid heartbeat, palpitations, shortness of breath, and chest pain after treatment.
Report liver symptoms
Report persistent anorexia, vomiting, abdominal pain, itchy skin, dark urine, and jaundice.
Report IV site symptoms immediately
Patients should immediately report IV site pain, redness, swelling, burning, stinging, or tightness.
Use reliable birth control
Patients should use reliable birth control during chemotherapy and avoid pregnancy.
Report pregnancy possibility
Patients should immediately tell the provider if pregnancy is likely.
Contraindications
Pregnancy risk category D and lactation
The image lists pregnancy risk category D and lactation. Modern labels no longer use pregnancy letter categories in the same way, but the key point remains: doxorubicin can harm a fetus, and breastfeeding is not recommended during therapy. DailyMed labeling advises not to breastfeed and warns about reproductive risk.
Existing bone marrow suppression
Patients with existing bone marrow suppression may be at higher risk of severe infection, anemia, and bleeding.
Cardiac disorders
Pre-existing cardiac disease increases risk of cardiotoxicity.
Obstructive jaundice
Obstructive jaundice suggests impaired bile flow and liver involvement, which can affect drug handling.
Previous doxorubicin or daunorubicin treatment
Patients who have already completed prior anthracycline therapy may have higher cumulative cardiac toxicity risk.
Precautions
Impaired liver function
Doxorubicin dosing may need adjustment in liver impairment.
Impaired kidney function
Kidney impairment requires caution and overall treatment monitoring.
Previous cyclophosphamide
Patients previously receiving cyclophosphamide may need extra caution because combination cancer therapy can increase toxicity.
Previous chemotherapy
Prior chemotherapy may increase risk of bone marrow suppression and organ toxicity.
Prior radiation near the heart
Radiation therapy near the heart increases cardiac risk when anthracyclines are used.
History of atrophic dermatitis
A history of atrophic dermatitis is listed as a precaution in the image.
Drug interactions
Barbiturates
Barbiturates may decrease the effect of doxorubicin.
QT-prolonging drugs
Drugs that prolong the QT interval on ECG may increase risk for cardiac effects.
Why QT matters
The QT interval reflects part of the heart’s electrical reset cycle. If it becomes too long, dangerous rhythm problems may occur.
Streptozocin
Streptozocin may prolong the half-life of doxorubicin.
Why half-life matters
A longer half-life means the drug stays in the body longer, which may increase toxicity risk.
Doxorubicin monitoring table
| What to monitor | Why it matters | Warning signs |
|---|---|---|
| CBC with differential | Detect neutropenia, anemia, thrombocytopenia | Fever, fatigue, bruising |
| Temperature | Detect infection early | Fever, chills |
| Platelets | Bleeding risk | Easy bruising, bleeding gums |
| Cardiac function | Cardiotoxicity risk | Chest pain, palpitations, breathlessness |
| Liver function | Hepatic toxicity | Dark urine, jaundice, itching |
| IV site | Extravasation risk | Pain, redness, swelling |
| Mouth | Stomatitis, yeast infection | Mouth pain, black hairy tongue |
| Urine color | Expected red discoloration | Persistent red urine or pain |
Doxorubicin and infection prevention
Why infection risk increases
Doxorubicin can lower white blood cells, especially neutrophils.
Best prevention habits
Patients should wash hands often, avoid sick people, maintain oral hygiene, eat safely prepared food, and report fever promptly.
Food safety
Wash fresh produce well and cook foods properly. Avoid foods that may carry infection risk if the oncology team recommends neutropenic precautions.
Visitors
Visitors with fever, cough, sore throat, diarrhea, or recent infection should avoid contact.
Doxorubicin and mouth care
Why mouth sores happen
Chemotherapy can irritate the lining of the mouth.
Prevention
Gentle brushing, soft toothbrush use, regular mouth rinsing, hydration, and avoiding spicy or acidic foods may help.
Report symptoms
Report pain in the mouth, ulcers, white patches, black hairy tongue, or difficulty swallowing.
Doxorubicin and hair loss
Why hair loss occurs
Hair follicles divide quickly, and chemotherapy affects rapidly dividing cells.
Is it reversible?
Hair loss is usually reversible after treatment ends.
Emotional impact
Hair loss can be emotionally difficult. Patients may benefit from counseling, head coverings, wigs, or support groups.
Doxorubicin and red urine
Why urine turns red
Doxorubicin is red-colored. After infusion, urine and tears may appear red or orange-red.
How long it lasts
The image notes it may last 1 to 2 days after infusion.
When to report
Report painful urination, blood clots, fever, or persistent red urine beyond the expected period.
Doxorubicin and heart safety
Why heart tests are needed
Doxorubicin can damage heart muscle. Baseline and follow-up cardiac testing help detect early changes.
Symptoms to report
Patients should report shortness of breath, chest pain, palpitations, swelling, fainting, or sudden severe fatigue.
Long-term follow-up
Cardiac effects can occur months or years later, so patients should tell future healthcare providers about past doxorubicin treatment.
Doxorubicin and extravasation
What extravasation means
Extravasation means chemotherapy leaks outside the vein.
Why it is serious
Doxorubicin can destroy tissue if it leaks. This may cause blistering, ulceration, necrosis, tendon damage, or nerve injury.
What patients should do
During infusion, patients should immediately report pain, burning, redness, swelling, or tightness at the IV site.
What staff should do
Stop the infusion immediately if extravasation is suspected and follow institutional protocol.
Doxorubicin vs liposomal doxorubicin
| Feature | Regular doxorubicin | Liposomal doxorubicin |
|---|---|---|
| Common name | Adriamycin | Doxil-type formulations |
| Form | IV solution | Liposomal IV infusion |
| Drug delivery | Standard anthracycline | Encapsulated in liposomes |
| Uses | Leukemia, lymphoma, breast, ovarian, sarcoma, etc. | Kaposi’s sarcoma, ovarian cancer, multiple myeloma, selected cancers |
| Key risks | Myelosuppression, cardiotoxicity, extravasation | Cardiotoxicity, infusion reactions, hand-foot syndrome depending on product |
| Interchangeable? | No | No |
Practical clinical scenarios
Scenario 1: Fever after chemotherapy
A patient develops fever 12 days after doxorubicin. This is near the expected WBC nadir period. The patient should contact the oncology team urgently because neutropenic infection is possible.
Scenario 2: Red urine after infusion
A patient notices red urine the day after treatment. This can be expected for 1 to 2 days. If it persists or comes with pain, fever, or clots, the patient should report it.
Scenario 3: IV site burning
A patient feels burning and swelling near the IV site during infusion. The infusion should be stopped immediately and staff should evaluate for extravasation.
Scenario 4: Palpitations after treatment
A patient reports rapid heartbeat and shortness of breath after doxorubicin. This may suggest cardiac effects and needs prompt evaluation.
Scenario 5: Easy bruising
A patient reports bruising and bleeding gums. This may suggest thrombocytopenia and needs blood count evaluation.
Did you know?
Did you know doxorubicin can turn urine red?
Red urine for 1 to 2 days after treatment can happen because the drug is red-colored. Patients should be warned so they do not panic.
Did you know the lowest WBC count often occurs after treatment?
The critical WBC nadir is commonly around 10 to 14 days after a dose, when infection risk may rise.
Did you know heart effects can appear late?
Doxorubicin-related cardiac problems may occur months or years after treatment, so long-term cardiac history matters.
Memory trick
Remember “DOXORUBICIN”
D – DNA-damaging anthracycline
O – Oncology drug for many cancers
X – eXtravasation causes tissue necrosis
O – Orange-red urine and tears
R – Reversible alopecia
U – Use CBC monitoring
B – Bone marrow suppression
I – Infection precautions
C – Cardiotoxicity
I – IV only with careful technique
N – Nadir 10 to 14 days
High-yield exam points
Drug class
Doxorubicin is an anthracycline antineoplastic drug.
Brand name
The common brand name is Adriamycin.
Main uses
It treats several cancers, including leukemias, lymphomas, Wilms’ tumor, neuroblastoma, sarcomas, thyroid cancer, bladder cancer, breast cancer, and ovarian cancer. Liposomal forms are used in selected cancers such as Kaposi’s sarcoma, ovarian cancer, and multiple myeloma.
Major adverse effects
Important adverse effects include severe bone marrow suppression, thrombocytopenia, anemia, alopecia, red urine and tears, cardiotoxicity, hepatotoxicity, thrombophlebitis, and extravasation injury.
Key monitoring
Monitor CBC with differential, temperature, bleeding, cardiac function, vital signs, liver function, and IV site condition.
Key patient teaching
Report fever, sore throat, easy bruising, unusual fatigue, mouth pain, bleeding, chest pain, palpitations, shortness of breath, dark urine, jaundice, IV site pain, redness, swelling, and possible pregnancy.
Key contraindications
Avoid or use only under strict specialist judgment in pregnancy, lactation, existing bone marrow suppression, cardiac disorders, obstructive jaundice, and prior completed anthracycline exposure.
FAQs about doxorubicin
What is doxorubicin used for?
Doxorubicin is used to treat many cancers, including acute leukemias, lymphomas, Wilms’ tumor, neuroblastoma, sarcomas, thyroid cancer, bladder cancer, breast cancer, and ovarian cancer. It may be used alone or with surgery, radiation therapy, or other chemotherapy medicines. Liposomal doxorubicin is used for selected cancers such as Kaposi’s sarcoma, ovarian cancer, and multiple myeloma. Treatment choice depends on cancer type and oncology protocol.
Is doxorubicin the same as Adriamycin?
Yes. Adriamycin is a common brand name for doxorubicin. The drug may also be available in different formulations, including regular IV doxorubicin and liposomal doxorubicin. These forms are not automatically interchangeable. The oncology team decides the correct product and dose.
Why is doxorubicin called the red devil?
Doxorubicin is sometimes nicknamed the “red devil” because the medicine is bright red and can cause strong chemotherapy side effects. This nickname is informal, but patients may hear it in cancer communities. The red color can also make urine and tears look red or orange-red for 1 to 2 days after infusion. Patients should still report persistent or painful urine changes.
What is the most serious side effect of doxorubicin?
The most serious side effects include cardiotoxicity, severe bone marrow suppression, and extravasation tissue injury. Cardiotoxicity can affect heart function and may appear during treatment or months to years later. Bone marrow suppression increases infection, anemia, and bleeding risk. Extravasation can cause tissue necrosis if the drug leaks outside the vein.
Why is CBC monitoring important with doxorubicin?
CBC monitoring is important because doxorubicin can suppress bone marrow. This can lower white blood cells, red blood cells, and platelets. Low white blood cells increase infection risk, low red blood cells cause anemia, and low platelets increase bleeding risk. The WBC nadir often occurs around 10 to 14 days after treatment.
Why does doxorubicin affect the heart?
Doxorubicin can damage heart muscle cells partly through oxidative stress and cumulative exposure. This can lead to cardiomyopathy or heart failure in some patients. Cardiac testing before, during, and after treatment helps detect problems early. Patients should report chest pain, palpitations, shortness of breath, swelling, or fainting.
What should patients report during IV infusion?
Patients should immediately report pain, burning, redness, swelling, tightness, or discomfort at the IV site. These may be signs of infiltration or extravasation. Doxorubicin extravasation can cause severe tissue injury. The infusion should be stopped immediately if extravasation is suspected.
Can doxorubicin cause hair loss?
Yes. Doxorubicin commonly causes alopecia, and complete hair loss may occur. This happens because chemotherapy affects rapidly dividing hair follicle cells. Hair loss is usually reversible after treatment ends. Patients may choose wigs, scarves, caps, or other supportive options.
Can doxorubicin be used during pregnancy?
Doxorubicin can harm a developing fetus and is generally avoided during pregnancy unless an oncology specialist determines that benefits outweigh risks in a specific situation. Patients should use reliable birth control during chemotherapy and report possible pregnancy immediately. Breastfeeding is not recommended during treatment. Reproductive planning should be discussed before therapy.
What interactions matter with doxorubicin?
Barbiturates may decrease doxorubicin’s effect. Drugs that prolong the QT interval may increase cardiac risk. Streptozocin can prolong the half-life of doxorubicin, which may increase toxicity. Patients should share a full medication list with their oncology team before treatment.
